A number of studies relating to the clinical value of serum leucine aminopeptidase determinations have already appeared (Arst, Manning, and Delp, 1959; Bressler, Forsyth, and Klatskin, 1960; Goggel, Creutzfeldt, and Murucas, 1960; Miller and Worsley, 1960; Pineda, Goldbarg, Banks. and Rutenburg, 1960a; Winsten and Seller, 1961) . It is now accepted that serum leucine aminopeptidase activity does not suffice for early diagnosis of cancer of the pancreas as had been thought originally (Rutenburg, Goldbarg, and Pineda, 1958) . The level of this enzyme is raised in serum almost exclusively in the presence of hepatobiliary and pancreatic disease (Arst et al., 1959; Hammond, Rosenak, and Khoo, 1960; Banks, Pineda, Goldbarg, and Rutenburg, 1960) . Concerning the differential diagnosis of jaundice there are conflicting views. It is the purpose of the present paper to report findings on 400 determinations of serum leucine aminopeptidase activity performed between May 1961 and January 1962.
MATERIALS AND METHODS
Serum leucine aminopeptidase activity was assayed by a method adopted by the Biochemical Department of Messrs. Boehringer and Soehne (Mannheim) derived from those of Green, Tsou, Bressler, and Seligman (1955) , Braun-Falco and Salfeld (1957) . Undiluted serum, 0-05 ml., was incubated with 2-5 ml. of the buffered substrate solution (L-leucyl-,8- serum leucine aminopeptidase activity was persistently raised. The same was found to occur in cases of chronic cholangiolitic hepatitis and biliary cirrhosis.
DISCUSSION
The results of the present study (Tables II and Ill) support the well-established view that serum leucine aminopeptidase is a specific and sensitive index of hepatobiliary disease (Arst et al., 1959; Bressler et al., 1960; Miller and Worsley, 1960; Banks et al., 1960) .
It is interesting to note that serum leucine aminopeptidase levels were elevated not only in the jaundiced patients but also in those not jaundiced, though to a much lower extent (Table II) . It must also be emphasized that in some cases of the anicteric group serum leucine aminopeptidase activity was raised whereas results of the commonly performed liver function tests (alkaline phosphatase and transaminases included) were normal. The above finding was observed in cases of acute hepatitis in the post-icteric phase (Fig. 2) , in one case of hepatic metastases, and in two cases of choledocholithiasis; on the other hand most anicteric patients with calculous cholecystitis (Table III) had a normal serum leucine aminopeptidase level. Similar findings have also been reported by Pineda, Goldbarg, and Rutenburg (1960b) . Some authors (Goggel, Kreutzfeldt, and Murucas, 1960; Pineda et al., 1960a and b; Shay, Sun, and Siplet, 1960) believe that biliary obstruction intraor extrahepatic is mainly responsible for raising serum leucine aminopeptidase levels though hepatic damage may also contribute to a lesser degree. Since leucine aminopeptidase is normally found in bile (Pineda et al., 1960a and b) it is possible that biliary obstruction impairs the excretion of this enzyme resulting in raised levels in serum. Against this concept and in favour of an overproduction theory, is the finding of raised serum leucine aminopeptidase activity in anicteric patients. Regardless of the pathogenetic mechanism of raised serum leucine aminopeptidase levels the interesting clinical viewpoint is whether a such highly elevated level in serum reflects the existence of cholestasis and whether this may be helpful in the differential diagnosis of jaundice. In our study values under 1.000 units were commonly observed in all groups of hepatobiliary disease. Values above 1,000 units have been found only in those cases in which biliary obstruction existed (cancer of the pancreas with jaundice, hepatic metastases, calculous biliary disease, chronic cholangiolitic hepatitis). It is therefore logical to assume that serum leucine aminopeptidase values under 1,000 units simply indicate the involvement of the hepatobiliary tract and that values above 1,000 indicate the existence of biliary obstruction,whatever its cause (malignant or benign) and localization (intrahepatic or extrahepatic). Further differentiation of the cause and the localization of biliary obstruction is not usually possible even with serial determinations.
It must be noted that extremely high values (above 2,000 units) were observed only in cases of obstructive jaundice due to cancer of the pancreas with hepatic metastases. This has been noted by other authors (Rutenberg, Goldbarg, and Pineda, 1958;  Despite a certain amount of disagreement, some authors (Goggel et al., 1960; Banks et al., 1960) consider that the serum leucine aminopeptidase test is a more sensitive index of biliary obstruction than the commonly performed non-specific serum alkaline phosphatase determination. In our study serum leucine aminopeptidase activity was always abnormal when alkaline phosphatase was elevated but not vice-versa. The scatter diagram (Fig. 1) shows no significant differences between leucine aminopeptidase and alkaline phosphatase in cases of obstructive jaundice if values of 1,000 leucine aminopeptidase units and 12 alkaline phosphatase Brodansky units are respectively taken as indicative of obstruction.
